Recent Advances in Inflammation and Allergy Drug Discovery Impact factor 2025

---

The latest impact factor of Recent Advances in Inflammation and Allergy Drug Discovery and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

Recent Advances in Inflammation and Allergy Drug Discovery: Aim & Scope

Recent Advances in Inflammation and Allergy Drug Discovery is a Web of Science indexed journal tha publishes research in the area: .
The ISSN of this journal is 27722716.

Impact factor of Recent Advances in Inflammation and Allergy Drug Discovery

Journal Title	Recent Advances in Inflammation and Allergy Drug Discovery
Impact Factor
SJR
ISSN	27722716
Quartile

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

Recent Advances in Inflammation and Allergy Drug Discovery

ISSN: 27722716
Journal Impact:
Journal Scope:

Recent advances in inflammation & allergy drug discovery

ISSN: 27722716
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q1)

RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY

ISSN: 2772-2716
Journal Impact: 1.2
Journal Scope: Pharmacology & Pharmacy

Recent Advances in Anti-Infective Drug Discovery

ISSN: 27724352
Journal Impact:
Journal Scope: Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3)

Recent Patents on Anti-Cancer Drug Discovery

ISSN: 22123970
Journal Impact: 2.5
Journal Scope: Oncology | Pharmacology & Pharmacy

Recent Advances in Drug Delivery and Formulation

ISSN: 26673886
Journal Impact:
Journal Scope: Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology

ISSN: 1710-1492
Journal Impact:
Journal Scope:

Allergy: European Journal of Allergy and Clinical Immunology

ISSN: 13989995
Journal Impact:
Journal Scope: Immunology (Q1); Immunology and Allergy (Q1)

Current Research in Pharmacology and Drug Discovery

ISSN: 25902571
Journal Impact:
Journal Scope: Animal Science and Zoology (Q1); Ecology, Evolution, Behavior and Systematics (Q1)

Letters in Drug Design and Discovery

ISSN: 15701808
Journal Impact:
Journal Scope: Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?